Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
MAP Kinase Family Gene Mutation: early-phase trial registry
1 of 1 indexed MAP Kinase Family Gene Mutation trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #11,433 of 28,963 conditions by registered trial count.
1 US clinical trials · 1 currently recruiting · #11,433 of 28,963 conditions by registered trial count
MAP Kinase Family Gene Mutation: 1 US clinical trial tracked, 1 recruiting.
MAP Kinase Family Gene Mutation is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Memorial Sloan Kettering Cancer Center, running 1 of these trials.
Enrollment posture brief
Registry condition map-kinase-family-gene-mutation
OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11433 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
MAP Kinase Family Gene Mutation lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for MAP Kinase Family Gene Mutation on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.
-
MAP Kinase Family Gene Mutation is recruiting above its size-band peers.
1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 28,061 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
1 total, page 1 of 1
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
Research context
Helpful clinical-trial guides
This page summarizes registry records, not medical advice or a recommendation to join a study. These guides explain how to interpret the information shown here and what to verify with a study team.
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.